LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor
2017 · Cell Metabolism · 348 citations
https://doi.org/10.1016/j.cmet.2017.10.016
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
384
Citations
2
h-index
2
i10-index
Hadas Galon-Tilleman is an academic researcher from NGM Biopharmaceuticals (United States). The author has contributed to research in topics: Regulation of Appetite and Obesity & Adipose Tissue and Metabolism & Biochemical Analysis and Sensing Techniques. The author has an h-index of 2, co-authored 2 publications.
Click to start Chat